<DOC>
	<DOCNO>NCT01180153</DOCNO>
	<brief_summary>To evaluate efficacy safety S-1 Oxaliplatin ( SOX ) regimen patient unresectable , metastatic locally advanced biliary tract ampullary adenocarcinoma .</brief_summary>
	<brief_title>Study S-1 Oxaliplatin ( SOX ) Biliary Tract Cancer ( BTC ) ( Ampullary Adenocarcinoma )</brief_title>
	<detailed_description>To list case unresectable , metastatic locally advanced biliary tract ampullary adenocarcinoma treat , confirm efficacy safety combine S-1/L-OHP regimen biliary tract ampullary carcinoma , provide evidence-based proof future treatment .</detailed_description>
	<mesh_term>Adenocarcinoma</mesh_term>
	<mesh_term>Biliary Tract Neoplasms</mesh_term>
	<mesh_term>Oxaliplatin</mesh_term>
	<criteria>1 . Informed consent sign subject ; 2 . Aged 18 ; 3 . With definite pathological cytological diagnosis adenocarcinoma ; 4 . No pretreatment ( include radiotherapy , chemotherapy , immunotherapy , etc. ) . For recurrent case , subject receive adjuvant chemotherapy without S1 LOHP surgery time end date adjuvant chemotherapy 6 month , also enrol ; 5 . Enhanced helical CT MRI scanning show target lesion 1cm within 14 day enrollment 6 . Within 7 day enrollment , baseline blood routine biochemical indicator meet follow criterion : Hemoglobin ≥ 90g/L , Absolute neutrophil count ( ANC ) ≥ 1.5 × 109/L , Platelets ≥ 100×109/L， Serum total bilirubin &lt; 1.5 time upper normal limit , Serum creatinine &lt; upper limit normal , Serum albumin ≥ 30 g/L ; 7 . Can receive oral administration ; 8 . Karnofsky ( KPS ) score ≥ 70 point ; 9 . Expected survival time 90 day ; 10 . Women childbearing age must receive urine blood pregnancy test within 7 day randomization result negative ; 11 . Male female patient appropriate reproductive age willing use reliable contraception method contraception process study till 30 day drug withdrawal . 1 . Patients severe drug allergy history ( include mildly allergic LOHP , 5FU , FT207 , 5HT3 receptor antagonist ) ; 2 . Patients participate participate clinical trial within 4 week enrollment ; 3 . Patients receive blood transfusion , blood product hematopoietic factor preparation GCSF within 15 day enrollment ; 4 . Patients undergone surgery within 15 day enrollment , effect eliminate ; 5 . Patients diarrhea ; 6 . Patients complication active infection ( infection cause fever 38 ℃ ) ; 7 . Patients accompany dysphagia , complete incomplete gastrointestinal obstruction , active gastrointestinal bleeding perforation , etc . cause difficulty take S1 orally ; 8 . Patients severe liver disease ( e.g . active hepatitis , cirrhosis , etc . ) , renal insufficiency , severe lung disease ( interstitial pneumonia , pulmonary fibrosis , severe emphysema , etc . ) , uncontrollable diabetes , hypertension chronic systemic disease ; 9 . Patients receive longterm systemic steroid therapy ( Note : shortterm user steroid withdrawal &gt; 2 week select ) ; 10 . Patients brain metastasis suspect brain metastasis ; 11 . Patients peripheral nervous system disorder history significant mental disorder central nervous system disorder ; 12 . Heart disease significant clinical symptom , e.g . congestive heart failure , coronary heart disease significant symptom , arrhythmia hypertension difficult control drug , episode myocardial infarction within 6 month , cardiac insufficiency ; 13 . Patients pleural effusion , ascites , pericardial effusion need drainage ; 14 . Pregnant breastfeed woman , male female patient appropriate reproductive age refuse take contraceptive measure ; 15 . Patients suffer malignancy within 5 year , except basal cell carcinoma carcinoma situ uterine cervix already cure ; 16 . Patients without legal capability , continue study due medical ethical reason ; 17 . Patients determine suitable participate clinical trial investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>74 Years</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>40 S-1/L-OHP</keyword>
	<keyword>biliary tract</keyword>
	<keyword>ampullary carcinoma</keyword>
</DOC>